Literature DB >> 15180858

Guidelines on the diagnosis and management of AL amyloidosis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15180858     DOI： 10.1111/j.1365-2141.2004.04970.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  16 in total

1.  Localized pleural amyloidosis: report of a case.

Authors:  Shohei Yoshiya; Riichiroh Maruyama; Takaomi Koga; Yasunori Shikada; Tokujiro Yano; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-06       Impact factor: 2.549

2.  Serum free light chain quantitative assays: Dilemma of a biomarker.

Authors:  Giovanni Cigliana; Francesca Gulli; Cecilia Napodano; Krizia Pocino; Elena De Santis; Luigi Colacicco; Iole Cordone; Laura Conti; Umberto Basile
Journal:  J Clin Lab Anal       Date:  2017-04-26       Impact factor: 2.352

Review 3.  Management of paraproteinaemia.

Authors:  Lucy Cook; Donald H C Macdonald
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

Review 4.  Cardiac amyloidosis: shifting our impressions to hopeful.

Authors:  Douglas B Sawyer; Martha Skinner
Journal:  Curr Heart Fail Rep       Date:  2006-06

5.  Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma.

Authors:  Sumit Madan; Angela Dispenzieri; Martha Q Lacy; Francis Buadi; Suzanne R Hayman; Steven R Zeldenrust; S Vincent Rajkumar; Morie A Gertz; Shaji K Kumar
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

6.  Successful management of refractory pleural effusion due to systemic immunoglobulin light chain amyloidosis by vincristine adriamycin dexamethasone chemotherapy: a case report.

Authors:  Toshikazu Araoka; Hiroya Takeoka; Keisuke Nishioka; Masaki Ikeda; Makiko Kondo; Azusa Hoshina; Seiji Kishi; Makoto Araki; Rokuro Mimura; Taichi Murakami; Akira Mima; Kojiro Nagai; Hideharu Abe; Toshio Doi
Journal:  J Med Case Rep       Date:  2010-10-18

7.  High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases.

Authors:  Nobuhiro Tsukada; Masahiro Ikeda; Sumito Shingaki; Kanji Miyazaki; Sohsuke Meshitsuka; Yumiko Yoshiki; Yu Abe; Kenshi Suzuki
Journal:  Int J Hematol       Date:  2015-12-24       Impact factor: 2.490

8.  Systemic AL amyloidosis with disseminated intravascular coagulation associated with hyperfibrinolysis.

Authors:  Toru Takahashi; Munehiro Suzukawa; Masaru Akiyama; Katsuhiro Hatao; Yukinori Nakamura
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

9.  Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.

Authors:  Chihiro Shimazaki; Shin-Ichi Fuchida; Kenshi Suzuki; Tadao Ishida; Hirokazu Imai; Morio Sawamura; Hiroyuki Takamatsu; Masahiro Abe; Toshihiro Miyamoto; Hiroyuki Hata; Masahito Yamada; Yukio Ando
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

Review 10.  Al amyloidosis.

Authors:  Estelle Desport; Frank Bridoux; Christophe Sirac; Sébastien Delbes; Sébastien Bender; Béatrice Fernandez; Nathalie Quellard; Corinne Lacombe; Jean-Michel Goujon; David Lavergne; Julie Abraham; Guy Touchard; Jean-Paul Fermand; Arnaud Jaccard
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.